We did indeed observe regulation of several factors denoting endothelial dysfunction (CD31, VCAM, thrombospondin) and tissue remodeling (MMP9, chitinase 3‐like 1) in IMRT, but not in SABR patients. The gene discussed is PECAM1; the disease is endothelial dysfunction.